COMP <GO>
J vs TMO // OPERATING MARGIN
Jacobs Solutions Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: J 6
— TMO 9
▲ OPERATING MARGIN LEADER: TMO
LAST: $154.62 (+1.22%) • MKT CAP: $17.88B
operating-margins
7.20%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (J VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | J | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 24.80% | 41.00% | -16.20 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 15.60% | 9.30% | +6.30 | J | /roic <GO> |
| EV/EBITDA & P/E Valuation | 20.2x | 30.4x | -10.20 | J | /valuation <GO> |
| Free Cash Flow Yield | 3.40% | 2.40% | +1.00 | J | /fcf-yield <GO> |
| Operating Margin ACTIVE | 7.20% | 17.40% | -10.20 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.40% | 15.10% | -12.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -1.10% | 3.90% | -5.00 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.86% | 0.24% | +0.62 | J | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.49 | 4.50 | -1.01 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.70% | +0.30 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 72.3 | 59.1 | +13.14 | J | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.94 | +0.08 | J | /macro-sensitivity <GO> |
| Forward P/E Multiple | 57.5x | 36.3x | +21.20 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $17.88B | $262.22B | -$244.34B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | J REV | TMO REV | J GROSS % | TMO GROSS % | J FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.03B | $44.56B | 24.8% | 44.0% | $607.5M | $6.29B |
| FY 2024 | $11.50B | $42.88B | 24.6% | 44.0% | $933.6M | $7.27B |
| FY 2023 | $0 | $42.86B | — | 44.0% | $974.8M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
J // BETA 1.02
TMO // BETA 0.94